<DOC>
	<DOCNO>NCT01863641</DOCNO>
	<brief_summary>The purpose study determine whether calcitriol effective treatment lupus nephritis .</brief_summary>
	<brief_title>The Effect Calcitriol Progress Activity Lupus Nephritis</brief_title>
	<detailed_description>Systemic lupus erythematosus ( SLE ) autoimmune disease renal involvement represent one common manifestation . On hand , evidence vitamin D analog know immunosuppressant property profound effect glomerular mesangial cell proliferation . Moreover much literature animal study suggest therapeutic intervention autoimmune disease . The investigator plan conduct double blind randomize control clinical trial study effect calcitriol progress activity lupus nephritis . Fifty patient clinically quiescent SLE biopsy-proven glomerulonephritis recruit . They treat calcitriol 1 year . Proteinuria , renal function , lupus disease activity , serum inflammatory marker monitor .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Lupus Nephritis</mesh_term>
	<mesh_term>Calcitriol</mesh_term>
	<criteria>Aged 1865 year Baseline Systemic Lupus Erythematosus Disease Activity Index score &lt; = 4 Estimated glomerular filtration rate 15 ml/min/1.73m2 Proteinuria &gt; 1 g/day ( proteinuria &gt; 1 g/gCr ) 2 consecutive sample within 12 week despite ACE inhibitor least 3 month On maintenance dose prednisolone &lt; 15 mg/day without immunosuppressive medication Serum calcium level normal range ( 8.510.5 mg/dl ) History biopsyproven lupus nephritis clinical quiescent SLE least 3 month Willingness give write consent comply study protocol Pregnancy , lactate childbearing potential without effective method birth control Severe gastrointestinal disorder interfere ability receive absorb oral medication History malignancy , include leukemia lymphoma within past 2 year ; Systemic infection require therapy study entry Any severe coexisting disease , limited , chronic liver disease , myocardial infarction , cerebrovascular accident , malignant hypertension History drug alcohol abuse within past 2 year Vitamin D deficiency ( 25 hydroxy vitamin D le 20ng/ml ) Participation previous trial vitamin D analogue Patients receive treatment vitamin D and/or analogue medical reason within past 4 week Patients take multivitamin supplement contain vitamin D could enrol 4 week wash period change preparation vitamin D On investigational drug within last 30 day History psychological illness condition interfere patient 's ability understand requirement study History noncompliance ; Known history sensitivity allergy vitamin D analog</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>lupus nephritis</keyword>
	<keyword>proteinuria</keyword>
	<keyword>SLE</keyword>
	<keyword>calcitriol</keyword>
</DOC>